Phase I dose-escalation trial investigating the safety and tolerability of EP0906 plus estramustine in patients with advanced cancer.

被引：0
|
作者：
Wojtowicz, M
Rothermel, JD
Anderson, J
Todd, M
Rubin, EH
Dipaola, RS
机构：
[1] Canc Inst New Jersey, New Brunswick, NJ USA
[2] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4623
引用
收藏
页码：412S / 412S
页数：1
相关论文
共 50 条
  • [31] Phase I trial of patupilone plus carboplatin in patients with advanced cancer.
    Gore, M
    Kaye, S
    Oza, A
    Keyzor, C
    Pyle, L
    Pereno, R
    Sklenar, I
    Zaknoen, S
    Johri, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 476S - 476S
  • [32] Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer
    Shepherd, FA
    Latreille, J
    Paul, K
    Eisenhauer, E
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 84 - 90
  • [33] Phase I/II dose-escalation and expansion study of afuresertib plus carboplatin and paclitaxel in recurrent ovarian cancer.
    Blagden, Sarah Patricia
    Gabra, Hani
    Hamilton, Anne L.
    Wong, Shirley S.
    Michael, Agnieszka
    Mileshkin, Linda R.
    Hall, Marcia
    Goh, Jeffrey
    Lisyanskaya, Alla Sergeevua
    DeSilvio, Michelle
    Habr, Dany
    Gainer, Shelby
    Gopalakrishna, Prashanth
    Meniawy, Tarek
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Phase I, open-label, dose-escalation trial investigating the safety and efficacy of oncolytic virus BI 1821736 in patients with advanced solid tumors.
    Tolcher, Anthony W.
    Victoria, Ivan
    Germann, Nathalie
    Luecke, Stephan
    Bailey, Mark
    Kordes, Maximilian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer
    Ullenhag, Gustav J.
    Rossmann, Eva
    Liljefors, Maria
    PLOS ONE, 2015, 10 (04):
  • [36] PHASE I DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND PHARMACOKINETICS OF ORAL ARTESUNATE IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (DESPARTH TRIAL)
    Vandewynckel, Y. -P.
    Rombauts, K.
    Verhelst, X.
    Van Bortel, L.
    De Spiegeleer, B.
    Geerts, A.
    Van Vlierberghe, H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S860 - S860
  • [37] Phase I dose-escalation, safety, and CNS pharmacokinetic study of dexanabinol in patients with brain cancer
    Juarez, Tiffany M.
    Piccioni, David
    Rose, Lara
    Nguyen, Angel
    Brown, Bradley
    Kesari, Santosh
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [38] A phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer.
    Geenen, Jill J. J.
    Dackus, Gwen
    Schouten, Philip C.
    Pluim, Dick
    Marchetti, Serena
    Sonke, Gabe S.
    Huitema, Alwin
    Beijnen, Jos H.
    Schellens, Jan H. M.
    Linn, Sabine C.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] A phase I dose-escalation study of BIBH-1 in patients with advanced or metastatic fibroblast activation protein positive cancer.
    Scott, AM
    Wiseman, G
    Welt, S
    Lee, FT
    Hopkins, W
    Mitchell, P
    Adjei, A
    Divgi, CR
    Larson, SM
    Hoffman, EW
    Tanswell, P
    Bette, P
    Vlock, D
    Amelsberg, A
    Rettig, W
    Old, LJ
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 311P - 311P
  • [40] Phase I dose-escalation study of the safety, tolerability, and pharmacokinetics of aflibercept in combination with S-1 in Japanese patients with advanced solid malignancies
    Toshihiko Doi
    Narikazu Boku
    Yusuke Onozawa
    Keishiro Takahashi
    Osamu Kawaguchi
    Atsushi Ohtsu
    Investigational New Drugs, 2020, 38 : 1390 - 1399
12345